Navigation Links
The Villa Group Informs on Mexico Travel Plans in Wake of Swine Flu Outbreak
Date:4/27/2009

SAN DIEGO, April 27 /PRNewswire/ -- The Villa Group is closely monitoring the recent swine flu outbreak in Mexico and has taken all appropriate steps to ensure the safety and health of all resort guests and employees. None of the Villa Group resort properties (located in Cabo San Lucas, Puerto Vallarta, and Nuevo Vallarta/Riviera Nayarit) are within close proximity to Mexico State where the outbreaks have occurred. No cases have been reported in any of the aforementioned destinations and The Villa Group is working closely with local authorities to take all necessary precautions to minimize exposure to the virus.

The Villa Group wishes to advise individuals with existing reservations who may be considering changes to their travel plans that they may do so without incurring any penalties from any of The Villa Group properties.

The Villa Group adheres to strict food handling and safety guidelines and will do everything required to ensure that the resort destinations remain unaffected. The reported influenza is taking place in Mexico City and has not spread to any of the resort destinations.

President Barack Obama said Monday the threat of spreading swine flu infections was a concern but "not a cause for alarm". Obama told a gathering of scientists that the Department of Health and Human Services "has declared a public health emergency as a precautionary tool" so that necessary resources are available as needed. Mexican authorities are working diligently with the Centers for Disease Control (CDC) and the World Health Organization (WHO) to assure early detection and warning as well as a quick proactive response.

For changes to existing reservations, contact The Villa Group toll free at 1-866-281-8457 or visit the website at www.villagroupresorts.com. For the latest information on the Swine Flu outbreak, please consult the State Depart
'/>"/>

SOURCE The Villa Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Photos: SOS Childrens Villages Observes World Orphan Week, October 5-11, 2008
2. Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments
3. InnoCentive and Nature Publishing Group Announce Partnership to Facilitate Open Innovation
4. New Report by BioTrends Research Group to Highlight the Launch of ULORIC(R) (febuxostat)
5. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
6. Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
7. Anpath Group, Inc. Advances Relationship With the Washington Metropolitan Area Transit Authority (Metro)
8. Encorium Group Signs $6.2 Million of New Contracts Mainly for Vaccines Clinical Trials
9. Consumer Group Urges Gov. Schwarzenegger to Sign Stem Cell Bill Into Law
10. Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
11. Anpath Group, Inc. Announces Approval of its Disinfectant by the State of Florida
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Feb. 27, 2015  PTC Therapeutics, Inc. (NASDAQ: ... reported financial results for the fourth quarter and full ... was a transformative year for PTC. We are now ... developing RNA-targeted therapies in the rare disease space," stated ... Inc. "We are proud to bring the first treatment ...
(Date:2/27/2015)... and JERUSALEM , Feb. 27, 2015 ... octreotide capsules, its lead product for the orphan condition ... Series E financing round. Participants in the financing included ... an undisclosed blue chip public investment fund, as well ... Health Ventures, Abingworth and ARCH Venture Partners. ...
(Date:2/26/2015)... 26, 2015  AbbVie (NYSE: ABBV ... in its neuroscience and oncology development programs have ... American Academy of Neurology annual meeting in ... 18-25. The accepted abstracts feature results from studies ... investigational treatments in AbbVie,s pipeline. Presentations will include ...
Breaking Medicine Technology:PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7
... Biotech AB,(Stockholm:ACTI.ST) and Chelsea Therapeutics International Ltd,(NASDAQ:CHTP) ... of an,I-3D compound. , The aim of ... of the compound in humans. The trial ... demonstrated that the selected I-3D compound,(ABR-224050) has ...
... PALO ALTO, Calif., March 14, 2007 /PRNewswire-FirstCall/ -- ... the of,Cardiology (JACC) has published data from the ... therapy with,Ranexa(R) (ranolazine extended-release tablets) to be safe ... who completed one,of two phase 3 clinical trials, ...
Cached Medicine Technology:Active Biotech's I-3D Micro-dosing Clinical Trial Concluded 2JACC Publishes Long-Term Safety and Tolerability Data from,Ranolazine Open Label Experience (ROLE) Program 2JACC Publishes Long-Term Safety and Tolerability Data from,Ranolazine Open Label Experience (ROLE) Program 3JACC Publishes Long-Term Safety and Tolerability Data from,Ranolazine Open Label Experience (ROLE) Program 4
(Date:2/28/2015)... Gerald “Solutionman” Haman surveyed over 10,000 people ... innovative thinking. “The #1 block was lack of ... reports Haman, who created the Thinkubator Innovation Studio in ... that they did not have enough time for innovative ... stimulate innovation. , Solutionman’s monthly “Accelerating Innovation Training” workshops ...
(Date:2/28/2015)... The Classic Denture Center , located ... Throughout all of March patients can receive $25 ... service can help overall mouth health and give ... notice certain symptoms that suggest the denture teeth are ... , 1.    Pain, clicking, and popping in the joints, 2.    Pain ...
(Date:2/28/2015)... Vancouver personal injury lawyers at Jiwa Law ... by time limits. They stated that in many cases, missing ... even nullify it. Many a time, delays in making an ... under BC law. As a result, experts at Jiwa Law ... consult a personal injury lawyer in order to know more ...
(Date:2/28/2015)... For those people who are unable ... Mesothelioma Applied Research Foundation (Meso Foundation) will broadcast ... starting at 9:30 AM. , The live broadcast is ... can be accessed through any browser on a computer ... Symposium is a unique event that covers important treatment ...
(Date:2/28/2015)... 28, 2015 National Sales ... sales, marketing and supply chain management for consumer ... is bringing its award winning solutions for thinning-damaged ... products are specifically created to combat thinning-damaged hair. ... is committed to marrying science with nature to ...
Breaking Medicine News(10 mins):Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 3Health News:Classic Denture Center in Portland Oregon is Offering March Discount 2Health News:Jiwa Law Corporation Recently Announced That Time Delays May Weaken Personal Injury Claims 2Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3
... later on, study suggests , , WEDNESDAY, March 26 (HealthDay ... linked to a softening of bones in a baby,s ... breast-feeding without vitamin D supplementation could prolong the deficiency, ... problems later in life, including decreased bone density and ...
... be the largest study of its kind for the genetic ... Crohns Disease as well as further evidence that some people ... The study examined changes in DNA associated with the two ... (CD), which is most frequently marked by inflammation of the ...
... BD (Becton,Dickinson and Company) (NYSE: BDX ) ... its second fiscal quarter 2008 earnings conference call on,Wednesday, ... issue a press release,detailing the quarter,s earnings earlier that ... be accessible through BD,s,website at http://www.bd.com/investors and ...
... of pediatric liver transplant recipients report lower health-related ... after the surgery, compared to reports from the ... dysfunction fall within the normal range. These findings ... Transplantation. The article is also available online at ...
... From the Underbelly, star Rachael Harris and ,Iron Chef, judge and,Mom-a-licious creator ... ... fundraiser, LOS ANGELES, March 26 The Fourth Annual Open Toe Shoe,Party ... Santa,Monica Hotel. The event will raise funds for The One Small Voice,Foundation., ...
... Adolescents receiving,comprehensive sex education had a substantially lower ... abstinence-only education or no,education at all, according to ... Adolescent Health., The study, conducted by Pamela ... E. Lafferty, M.D., also concluded that teaching about,contraception ...
Cached Medicine News:Health News:Too Little Vitamin D May Soften Baby's Skull 2Health News:Large multicenter study suggests new genetic markers for Crohn's disease 2Health News:Study shows lifetime effects of pediatric liver transplants 2Health News:Celebrities From All Walks of Life Put Their Best Foot Forward for the Fourth Annual Open Toe Shoe Party 2Health News:New Study -- Same Result! Comprehensive Sex Education Works 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: